Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
$5.44
-0.4500 ( -7.64% ) 646.3K
BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.
Market Data
Open
$5.44
Previous close
$5.89
Volume
646.3K
Market cap
$4.45M
Day range
$4.95 - $5.80
52 week range
$2.23 - $13.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Jul 15, 2024 |
6-k | Quarterly Reports | 2 | Jul 15, 2024 |
6-k | Quarterly Reports | 5 | Jul 08, 2024 |
6-k | Quarterly Reports | 2 | Jul 08, 2024 |
6-k | Quarterly Reports | 2 | Jul 08, 2024 |
6-k | Quarterly Reports | 46 | Jun 14, 2024 |
6-k | Quarterly Reports | 2 | Jun 13, 2024 |
6-k | Quarterly Reports | 2 | Jun 13, 2024 |
6-k | Quarterly Reports | 2 | May 28, 2024 |
20-f | Annual reports | 92 | May 15, 2024 |